title: Acquired glomerular lesions in patients with Down syndrome.
abstract: The long-term survival of persons with Down syndrome has dramatically increased over the past 50 years. There are no studies addressing the spectrum of glomerular lesions in these patients. We reviewed the clinical-pathologic characteristics of 17 patients with Down syndrome who underwent renal biopsy. The cohort consisted of 12 whites and 5 African Americans with mean age of 29 years (range, 6-45 years). History of hypothyroidism was present in 8 patients. Renal presentations included renal insufficiency (15 patients, mean serum creatinine 3.4 mg/dL), proteinuria (all patients, including 3 with nephrotic syndrome, mean 24-hour urine protein 4.2 g), and hematuria (14 patients, including 4 with gross hematuria). The glomerular diseases found on biopsy were IgA nephropathy (n = 5 patients), focal segmental glomerulosclerosis (n = 4), membranoproliferative glomerulonephritis (n = 2), acute postinfectious glomerulonephritis (n = 2), pauci-immune crescentic glomerulonephritis (n = 2), membranous glomerulonephritis (n = 1), and lupus nephritis (n = 1). Follow-up (mean, 47 months; range, 2-141 months) was available on 16 patients (94%). Two patients (1 with membranous glomerulonephritis and 1 with acute postinfectious glomerulonephritis) had complete remission; 8 patients (4 with IgA nephropathy, 2 with focal segmental glomerulosclerosis, 1 with lupus nephritis, and 1 with acute postinfectious glomerulonephritis) had chronic kidney disease; and 6 patients (2 with pauci-immune crescentic glomerulonephritis, 2 with membranoproliferative glomerulonephritis, 1 with IgA nephropathy, and 1 with focal segmental glomerulosclerosis) progressed to end-stage renal disease, 4 of whom died. In summary, a wide spectrum of glomerular diseases can be seen in patients with Down syndrome, with IgA nephropathy and focal segmental glomerulosclerosis being the most common. Renal biopsy is necessary to determine the type of glomerular lesion and appropriate treatment.
authors: Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN 55905, USA.
authors: Samar M
authors: SM
authors: Said
authors: Lynn D
authors: LD
authors: Cornell
authors: Sanjeev
authors: S
authors: Sethi
authors: Mary E
authors: ME
authors: Fidler
authors: Omar
authors: O
authors: Al Masri
authors: Jeffrey
authors: J
authors: Marple
authors: Samih H
authors: SH
authors: Nasr
mesh_terms: D000293:Adolescent; D000328:Adult; D002648:Child; D015331:Cohort Studies; D015897:Comorbidity; D004314:Down Syndrome / Q000453:epidemiology* / Q000401:mortality / Q000473:pathology; D005260:Female; D005922:Glomerulonephritis, IGA / Q000453:epidemiology* / Q000401:mortality / Q000473:pathology; D005923:Glomerulosclerosis, Focal Segmental / Q000453:epidemiology* / Q000401:mortality / Q000473:pathology; D006801:Humans; D007037:Hypothyroidism / Q000453:epidemiology / Q000473:pathology; D007678:Kidney Glomerulus / Q000473:pathology*; D008297:Male; D008875:Middle Aged; D008910:Minnesota / Q000453:epidemiology; D051437:Renal Insufficiency / Q000453:epidemiology* / Q000473:pathology; D015996:Survival Rate